BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35090205)

  • 41. [Effects of radical radiotherapy combined with different regimens of chemotherapy on radiation intestinal injury in patients with non-metastatic anal squamous cell carcinoma].
    Pang XL; Liu S; Liu YP; Chen HY; He F; Zheng J; Wan XB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):977-983. PubMed ID: 34823298
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Yabuki K; Arai Y; Takahashi H; Hata M; Koike I; Oridate N
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1147-54. PubMed ID: 24658628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Outcomes of Definitive and Postoperative Radiotherapy for Stage I-IVB Hypopharyngeal Cancer.
    Shirai K; Saitoh JI; Musha A; Abe T; Kobayashi D; Takakusagi Y; Takaysu Y; Shino M; Toyoda M; Takahashi K; Chikamatsu K; Ohno T; Nakano T
    Anticancer Res; 2016 Dec; 36(12):6571-6578. PubMed ID: 27919985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer--does tumor volume correlate with central necrosis and tumor pathology?
    Tsou YA; Hua JH; Lin MH; Tsai MH
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):206-12. PubMed ID: 16508339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck.
    Papazian MR; Chow M; Oliver J; Gordon AJ; Jacobson A; Vaezi A; Tam M; Givi B
    Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1411-1419. PubMed ID: 36892056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contribution of neck dissection for residual neck disease after chemoradiotherapy in advanced oropharyngeal and hypopharyngeal squamous cell carcinoma patients.
    Suzuki M; Kawakita D; Hanai N; Hirakawa H; Ozawa T; Terada A; Omori K; Hasegawa Y
    Int J Clin Oncol; 2013 Aug; 18(4):578-84. PubMed ID: 22588781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
    Kuo P; Sosa JA; Burtness BA; Husain ZA; Mehra S; Roman SA; Yarbrough WG; Judson BL
    Cancer; 2016 Jun; 122(12):1853-60. PubMed ID: 27019213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Long-term outcome of patients with pyriform sinus squamous cell carcinoma treated with planned preoperative (chemo-) radiotherapy plus laryngeal function sparing surgery].
    Huang H; Zhang ZM; Zhang Y; Wang XL; Liu SY; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):535-539. PubMed ID: 31357842
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical study and survival analysis of combined modality therapies for advanced hypopharyngeal carcinoma].
    Shi Q; Li W; Li G; Zhang C; Fang X; Wu L; Zhang L; Liao Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 27(4):206-9. PubMed ID: 23631137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of Advanced-stage Hypopharyngeal Carcinoma: 25-Year Experience from a Tertiary Care Medical Center.
    Vengaloor Thomas T; Nittala MR; Bhanat E; Albert AA; Vijayakumar S
    Cureus; 2020 Jan; 12(1):e6679. PubMed ID: 32104619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
    Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
    Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
    Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salvage surgery for recurrence of laryngeal and hypopharyngeal squamous cell carcinoma: A retrospective study from 2005 to 2013.
    Pujo K; Philouze P; Scalabre A; Céruse P; Poupart M; Buiret G
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Apr; 135(2):111-117. PubMed ID: 29198646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting Factors for Oncological and Functional Outcome in Hypopharyngeal Cancer.
    Visini M; Giger R; Shelan M; Elicin O; Anschuetz L
    Laryngoscope; 2021 May; 131(5):E1543-E1549. PubMed ID: 33098325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors in patients with advanced hypopharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Krstevska V; Stojkovski I; Zafirova-Ivanovska B; Crvenkova S
    J BUON; 2012; 17(2):327-36. PubMed ID: 22740214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of neutrophil-to-lymphocyte ratio with severe radiation-induced mucositis in pharyngeal or laryngeal cancer patients: a retrospective study.
    Kawashita Y; Kitamura M; Soutome S; Ukai T; Umeda M; Saito T
    BMC Cancer; 2021 Sep; 21(1):1064. PubMed ID: 34583669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival differences between definitive radiotherapy and surgery followed by adjuvant radiotherapy in supraglottic and hypopharyngeal carcinoma.
    Zhang M; Gao XS; Qin Y; Sun Y; Ma MW
    Chin Med J (Engl); 2019 Nov; 132(22):2698-2704. PubMed ID: 31765356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment effect of concurrent chemoradiotherapy after surgery and its effect on postoperative swallowing function of patients with locally advanced hypopharyngeal carcinoma.
    Wang X; Wang L; Gao L; Guo X; Cao H
    J BUON; 2021; 26(5):2003-2009. PubMed ID: 34761610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.